Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06135701
Other study ID # H-23049997
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 21, 2023
Est. completion date January 12, 2024

Study information

Verified date January 2024
Source Rigshospitalet, Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Doppler ultrasound is generally considered to provide reliable femoral blood flow measurements between rest and exercise, and the blood flow response to exercise is widely believed to be reduced in patients with chronic obstructive pulmonary disease (COPD). However, the test-retest reliability of the method during one-leg knee extensor exercise has not previously been compared between matched healthy individuals.


Description:

Experimental assessments of changes in skeletal muscle blood flow during exercise in humans are important for elucidating the factors that limit exercise capacity and adaptations, both in healthy humans, including athletes, as well as in various disease states with functional impairment, such as chronic obstructive pulmonary disease COPD). A classical 'gold standard' for measuring blood flow is thermodilution, and this has notably applied to provide data on femoral blood flow during exercise. Because thermodilution required invasive catheterization, many have replaced it with Doppler ultrasound, but the test-retest reliability of Doppler ultrasound in this context is unknown. However, many studies have used Doppler ultrasound to document that the femoral blood flow response to exercise is impaired in COPD, which ultimately affects oxygen uptake and thus exercise capacity, but the interpretation of these findings is currently hampered by the lack of knowledge regarding the test-retest reliability of the method in this patient group. The investigators aim is to compare the femoral blood flow response to one-legged knee extensor exercise in patients with COPD vs. healthy participants, and to provide an estimate of the test-retest reliability the femoral blood flow measurements obtained by Doppler ultrasound.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date January 12, 2024
Est. primary completion date January 12, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 80 Years
Eligibility Inclusion Criteria for COPD patients: - Men and women - 45-80 years - COPD (GOLD stage I to III) - Forced expiratory volume in 1 sec (FEV1)/forced vital capacity ratio (FVC) < 0.8, FEV1 < 90% of predicted value - Modified Medical Research Council score (mMRC 0 - 3) Resting arterial oxygenation > 90% Exclusion Criteria for COPD patients: - Symptoms of ischaemic heart disease - Known heart failure - Claudication - Symptoms of disease within 2 weeks prior to the study - Participation in pulmonary rehabilitation within 6 months - Known malignant disease - Pregnancy - Unstable cardiac arrhythmic disease - Renal or liver dysfunction Inclusion Criteria for healthy matched controls: - Men and women - 45-80 years - Normal FEV1, FVC, FEV1/FVC, and single-breath diffusion capacity - Same sex, age (± 3 years) as the COPD patients Exclusion Criteria for healthy matched controls: - Known chronic lung disease - Known ischaemic heart disease - Known heart failure - Symptoms of disease within 2 weeks prior to the study - Known malignant disease - Claudication - Pregnancy - Unstable cardiac arrhythmic disease - Renal or liver dysfunction

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
One-legged knee-extensor exercise with Doppler measurements
Doppler ultrasound is used while participants exercise according to the one-legged knee-extensor exercise model

Locations

Country Name City State
Denmark Center for Aktiv Sundhed (CFAS), Rigshospitalet, Copenhagen, Denmark. Copenhagen København Ø

Sponsors (1)

Lead Sponsor Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Between-day smallest real difference (SRD) for femoral blood flow at rest and at each relative exercise intensity in COPD vs. healthy controls Doppler ultrasound measured blood flow during one leg knee extensor exercise with different intensities. Measured at day 1 and day 2
Primary • Between-day coefficient of variance (CV) for femoral blood flow at rest and at each relative exercise intensity in COPD vs. healthy controls (co-primary) Doppler ultrasound measured blood flow during one leg knee extensor exercise with different intensities. Measured at day 1 and day 2
Secondary Femoral blood flow response to exercise at each relative exercise intensity in COPD vs. healthy controls (key secondary) Doppler ultrasound measured blood flow during one leg knee extensor exercise with different intensities. Measured at day 1 and day 2
Secondary Between-day smallest real difference (SRD) for femoral blood flow at rest and at each absolute exercise intensity in COPD vs. healthy controls Doppler ultrasound measured blood flow during one leg knee extensor exercise with different intensities. Measured at day 1 and day 2
Secondary • Between-day coefficient of variance (CV) for femoral blood flow at rest and at each absolute exercise intensity in COPD vs. healthy controls (co-primary) Doppler ultrasound measured blood flow during one leg knee extensor exercise with different intensities. Measured at day 1 and day 2
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1